6 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 6 |
| Phase 2 | 1 | Unknown 1 |
Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder Alkalinized Lidocaine, Placebo Sodium Chloride 0.9% Inj - Urge Incontinence, Overactive Bladder | Phase 3 | Unknown | Herlev and Gentofte Hospital | 50 | 2022-09-12 | 2022-09-22 |
| Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder Neuronox, Placebo - Overactive Bladder | Phase 3 | Unknown | Medy-Tox | 216 | 2019-08-23 | 2020-07-28 |
| Low-level Light Therapy for Overactive Bladder and Urinary Incontinence Low-level light therapy, Placebo - Overactive Bladder, Urinary Incontinence | Phase 3 | Unknown | Seoul National University Hospital | 120 | 2016-12-01 | 2016-12-07 |
| A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB) Botulinum Toxin Type A for Injection, Placebo - Overactive Bladder | Phase 3 | Unknown | Lanzhou Institute of Biological Products Co., Ltd | 216 | 2016-03-01 | 2018-01-03 |
| OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER onaBoNT-A, Oxybutynin ER - Overactive Bladder | Phase 3 | Unknown | Christopher Patrick Smith | 36 | 2013-08-01 | 2016-08-30 |
| This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. Botox - Overactive Bladder | Phase 2 / Phase 3 | Unknown | Urological Sciences Research Foundation | 40 | 2007-01-01 | 2007-05-30 |
Urinary Incontinence (2) · Hematuria (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Pain, Procedural (1) · Spinal Cord Injuries (1) · Urinary Incontinence, Urge (1) · Urinary Tract Infections (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Lower Urinary Tract Symptoms (6) · Male Urogenital Diseases (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Urinary Bladder Diseases (6) · Urogenital Diseases (6) · Urologic Diseases (6) · Urological Manifestations (6) · Urination Disorders (3) · Central Nervous System Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1)
Botulinum Toxins, Type A (4) · Hengli BTX-A (1) · Injections (1) · Low-Level Light Therapy (1) · Tolterodine Tartrate (1) · onabotulinum toxin A (1) · oxybutynin (1)
Christopher Patrick Smith (1) · Herlev and Gentofte Hospital (1) · Lanzhou Institute of Biological Products Co., Ltd (1) · Medy-Tox (1) · Seoul National University Hospital (1) · Urological Sciences Research Foundation (1)
South Korea (2) · United States (2) · Denmark (1)
Christopher P. Smith, MD (1) · Leonard S Marks, M.D. (1) · Niels Klarskov, Prof,MD,DMSc (1) · Yong Beom Kim, Professor (1)